1Simon DD,Chantal P,David R.Williamson Brain natriuretic peptide in the management of heart failure:the versatile neurohormone[J].Chest,2004,125:652-668.
2Cowie MR,Mendez GF.BNP and congestive heart failure[J].Prog Cardiovasc Dis,2002,44(4):293-321.
3European Society of Cardiology.Task force for the diagnosis and treatment of chronic heart failure.Guideline for the diagnosis and treatment of chronic heart failure[J].Eur Heart J,2001,22:1527-1560.
4Maisel AS,Krishnaswamy P,Nowak RM,et al.Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure[J].N Engl J Med,2002,347(3):161.
5McDonagh TA,Robb SD,Murdoch DR,et al.Biochemical detection of left ventricular systolic dysfunction[J].Lancet,1998,351(9095):9-13.
6Toru S,Kazuhide Y,Osamu N,et al.Screening for cardiac dysfunction in asymptomatic patients by measuring B-type natriuretic peptide levels[J].Jpn Heart J,2000,41(2):205-214.
7Nielsen OW,McDonagh TA,Rohb SD,et al.Reprospective analysis of thecost-effectiveness of using plasmabrain natriuretic peptide inscreening for left ventricularsystolic dysfunction in the general population[J].J Am Coll Cardiol,2003,41(1):113.
1Packer M.Survival in patients with chronic heart failure and its potential modification by drug therapy.In Cohn,J.N(ed):Drug treatment of heart failure[M].2nd ed.Secaucus:N J ATC international,1988.273.
2European society of cardiology.Task force for the diagnosis and treatment of chronic heart failure.Guideline for the diagnosis and treatment of chronic heart failure[J].Eur Heart J,2001,22,1527-1560.
3DeBold AJ,Borenstein HB,Veress AT,et al.A rapid and potent natriudic response to intravenous injection of atrial myocandial extract in rats[J].Life Sci,1981,28,89-94.
4Sudoh T,Kangawa K,Minamino N,et al.A new natriuretic peptide in porcine brain[J].Nature,1988,332:78-81.
5Nakao K,Ogawa Y,Suga S,et al.Molecular biology and biochemistry of the natriuretic peptide system I:natriuretic peptides[J].J Hypertens,1992,10:907-912.
6Salomon P,Przewlocka-Kosmala M,Orda A,etal.Plasma levels of brain natriuretic peptide,cyclic 3'5'-guanosine monophosphate,endothelin-1 and noradrenaline in patients with chronic congestive heart failure[J].Pol Arch Med Wewn,2003,109(1):43-48.
7Mukoyama A,Nakao K,Hosoda K,et al.Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure[J].Eur J Clin Invest,1998,28(8):636-642.
8Maeda K,Tsutamoto T,Wada A,et al.High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heartfailure[J].J Am Coil Cardiol,2000,36(5):1581-1593.
9Brian P,Shapiro MD,Horng H,et al.Use of plasma brain natriuretic peptide concentration to aid in the diagnosis of heart failure[J].Mayo Clin Proc,2003,78:481-486.
10Burger AJ,Horton DP,Elkayam U,et al.Nesiritide is not associated with the proarrhythmic effects of dobutamine in the treatment of decompensated CHF:The precedent study[J].J Card Fail,1999,5:49.
4Simon DD, Chantal P, David R. Williamson Brain natriuretic peptide in the management of heart failure : the versatile neurohormone [ J ]. Chest, 2004,125 ( 2 ) :652-668.
5Tamura N, Ogaw Y, Chusho H, et al. Cardiac fibrosis inm ice lacking brain natriuretic pep tide [ J ]. Proc NatlAcad Sci USA, 2000,97 ( 8 ) : 4239.
6Aldo C, Marianna F, Lue Z, et al. Canparison of the diagnostic accuracy of brain natriuretic peptide(BNP) and the N-tern inal part of the propeptide of BNP inmunoassays in chronic and acute heart failure [J]. Clin Chem,2007,53(5) :813-822.
7European Society of Cardiology. Task force for the diagnosis and treatment of chronic heart failure Guideline for the diagnosis and treatment of chronic heart failure [ J ]. Eur Heart, 2001,22 ( 17 ) : 1527- 1560.
8Maisel A. B-type natriuretic peptide levels:a potential novel "white count" for congestive heart failure[J]. J Card Fall,2001,7(2) :183- 193.
9Kelly R, Struthers AD. Are natriuretie peptides clinically uaeful as markers of heart failure? [J]. Ann Clin Biochem,2001,38 (Pt 2) : 94-102.
10Mc Donagh TA, Robb SD, Muedoch DR, et al. Biochemical detection of left ventricular systolic dysfunction [ J ]. Lancet, 1998,351:9213.
